These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5075930)

  • 21. [Late results of conservative therapy of arterial occlusive diseases].
    Schoop W
    Internist (Berl); 1984 Jul; 25(7):429-33. PubMed ID: 6236161
    [No Abstract]   [Full Text] [Related]  

  • 22. [Indications for and limitations of fibrinolytic therapy in vascular occlusions of the retina].
    Leydhecker W; Krieglstein GK; Brunswig D
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1978; (75):396-9. PubMed ID: 743127
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of stent thrombosis after lower-extremity endovascular revascularization: which is the optimal antithrombotic therapy and is early strenuous exercise safe?
    Ambrosetti M; Tozzi M; Piffaretti G; Barosi A; Caronno R; Poggio G; Castelli P
    Minerva Cardioangiol; 2008 Apr; 56(2):261-2. PubMed ID: 18319707
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents].
    Martínez Sande JL; González-Juanatey JR; García-Acuña JM; Amaro Cendón A; Fernández Vázquez F; Fernández López JA; García Seara J; Vega Fernández JM; López Lago A; Gil de la Peña M
    Med Clin (Barc); 1997 Oct; 109(14):532-7. PubMed ID: 9580043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
    Comerota AJ
    Thromb Res; 2008; 122 Suppl 3():S20-6. PubMed ID: 18701142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal therapeutic approaches to femoropopliteal artery intervention.
    Das T
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):21-30. PubMed ID: 15343563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibility of angiological intensive therapy in arterial occlusive disease].
    Grossmann K; Kulick B; Banzhaf E
    Z Gesamte Inn Med; 1977 Oct; 32(19):504-8. PubMed ID: 595724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the problem of the thrombolytic effect of heparin and nicotinic acid].
    Rasche H; Hiemeyer V
    Med Klin; 1968 Jan; 63(2):63-5. PubMed ID: 4175296
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombolytic therapy for arterial occlusion: a mixed blessing.
    Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
    Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of thrombolysis in the management of acute arterial occlusions of the lower limb.
    Browning NG; Barry R; Nel CJ
    S Afr J Surg; 1995 Dec; 33(4):170-4. PubMed ID: 8677470
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary results of transluminal dilation in the treatment of peripheral arterial occlusive disease.
    Kalman PG; Colapinto RF; Harries-Jones EP; Silver MD; Johnston KW
    Surg Gynecol Obstet; 1980 Jun; 150(6):865-8. PubMed ID: 7376049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angioplasty treatment for peripheral vascular disease.
    Iannone L; Rough R; Ghali M; Rayl KL; Phillips S
    Iowa Med; 1996 Sep; 86(7):281-3. PubMed ID: 8854576
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of the new thrombolytic substance plasmakinase to treat acute experimental coronary artery thrombosis].
    Khvatov VB; Galankina IE; Maksimovich IV
    Grudn Khir; 1983; (4):22-32. PubMed ID: 6354883
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease].
    Hoffmann J
    Med Welt; 1982 Jul; 33(28):1034-7. PubMed ID: 6922390
    [No Abstract]   [Full Text] [Related]  

  • 37. [Methods of catheterization of the inferior epigastric artery and long-term intra-arterial infusion of drugs in the treatment of chronic osteomyelitis of the lower extremities].
    Kanorskiĭ ID; Svetukhin AM
    Sov Med; 1973 Oct; 36(10):94-9. PubMed ID: 4789222
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with brinase.
    Frisch EP
    J Clin Pathol; 1972 Jul; 25(7):654-5. PubMed ID: 5070274
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lysis of experimentally produced arterial thrombi by means of local application of ocrase in the dog].
    Sedlarik K; Perlewitz J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):117-22. PubMed ID: 58810
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment and clinical outcome in patients with basilar artery occlusion.
    Schonewille W; Wijman C; Michel P;
    Stroke; 2006 Sep; 37(9):2206; author reply 2207. PubMed ID: 16902170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.